Maven Securities LTD Gilead Sciences, Inc. Transaction History

Maven Securities LTD

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 04, 2023	BUY	$76.01 - $86.7 $500,145 - $570,486	6,580 New	6,580 $507,000
Q3 2022 Nov 14, 2022	BUY	$59.54 - $68.01 $865,652 - $988,797	14,539 New	14,539 $8.97 Million
Q1 2022 May 16, 2022	SELL	$57.92 - $72.58 $202,893 - $254,247	-3,503 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$64.88 - $73.64 $227,274 - $257,960	3,503 New	3,503 $254,000
Q1 2021 May 17, 2021	SELL	$60.0 - $68.46 $1.22 Million - $1.39 Million	-20,269 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$56.65 - $64.55 $269,427 - $306,999	4,756 Added 30.66%	20,269 $1.18 Million
Q3 2020 Nov 13, 2020	BUY	$62.1 - $78.08 $567,097 - $713,026	9,132 Added 143.11%	15,513 $974,000
Q2 2020 Aug 14, 2020	BUY	$72.34 - $84.0 $461,601 - $536,004	6,381 New	6,381 $491,000

1,893

1.02B

12M

9.04M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $110B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Maven Securities LTD, based on Form 13F filings with the SEC.

Stay updated on Maven Securities LTD with notifications on news.